Cigna Corp
NYSE:CI
Price/Premiums
Price to Premiums
Market Cap | Price/Premiums | ||||
---|---|---|---|---|---|
US |
Cigna Corp
NYSE:CI
|
97.6B USD | 0 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
90.3B EUR | 0 | |
US |
CVS Health Corp
NYSE:CVS
|
70.4B USD | 0 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
18B USD | 0 | ||
DE |
Fresenius SE & Co KGaA
XETRA:FRE
|
16.1B EUR | 0 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.6B USD | 0 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12.3B EUR | 0 | |
DE |
Fresenius Medical Care AG
XMUN:FME
|
12B EUR | 0 | ||
US |
DaVita Inc
NYSE:DVA
|
12.1B USD | 0 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 0 | ||
US |
Chemed Corp
NYSE:CHE
|
8.6B USD | 0 |
Price/Premiums Forward Multiples
Forward Price/Premiums multiple is a version of the Price/Premiums ratio that uses forecasted gross premiums earned for the Price/Premiums calculation. 1-Year, 2-Years, and 3-Years forwards use gross premiums earned forecasts for 1, 2, and 3 years ahead, respectively.